Search This Blog

Wednesday, November 6, 2019

Acceleron Pharma EPS misses by $0.04, misses on revenue

Acceleron Pharma (NASDAQ:XLRN): Q3 GAAP EPS of -$0.86 misses by $0.04.
Revenue of $4.21M (+29.1% Y/Y) misses by $0.23M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)